NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球生物醫藥品分析實驗服務市場:2020年∼2024年的預測

Biopharmaceutical Analytical Testing Services Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 672868
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球生物醫藥品分析實驗服務市場:2020年∼2024年的預測 Biopharmaceutical Analytical Testing Services Market 2020-2024
出版日期: 2020年01月30日內容資訊: 英文 120 Pages
簡介

全球生物醫藥品分析實驗服務市場在預測期間內預計將以9%的年複合成長率成長,2024年達到11億8,000萬美元的規模。該市場的成長主要因素為專利到期醫藥品數的增加。還有分析實驗服務的外包增加,預計推動該市場的成長。

本報告提供全球生物醫藥品分析實驗服務市場的相關調查,市場成長要素,趨勢和課題,各終端用戶、地區的市場分析,業者情勢,主要企業的簡介等資訊。

目錄

摘要整理

  • 市場概況

市場預測

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2019年
  • 市場預測:2019-2024年的預測

波特的五力分析

  • 五力摘要
  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

市場分析:各終端用戶

  • 市場區隔
  • 比較
  • 製藥及生物科技企業
  • CRO
  • 市場機會

客戶情勢

  • 概要

市場分析:各地區

  • 市場區隔
  • 比較
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
  • 主要國家
  • 市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量成長要素:需求主導的成長
  • 交易量成長要素:供給主導的成長
  • 交易量成長要素:外部要素
  • 交易量成長要素:相關市場上的需求轉移
  • 價格成長要素:通貨膨脹
  • 價格成長要素:從低價格轉移到高價格
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 形勢的創新

企業簡介

  • 交易廠商
  • 供應商的市場定位
  • Boston Analytical
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Eurofins Scientific
  • Intertek Group PLC
  • Merck KGaA
  • SGS SA
  • Solvias AG
  • STERIS Plc
  • West Pharmaceutical Services Inc.

附錄

  • 報告的範圍
  • 美金的匯率
  • 調查方法
  • 簡稱的清單
目錄
Product Code: IRTNTR40457

Global Biopharmaceutical Analytical Testing Services Market 2020-2024

Technavio has been monitoring the global biopharmaceutical analytical testing services market and it is poised to grow by USD 1.18 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on global biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in number of patent-expired drugs.In addition, increasing outsourcing of analytical testing services is anticipated to boost the growth of the global biopharmaceutical analytical testing services market as well.

Market Segmentation

Technavio's global biopharmaceutical analytical testing services market is segmented as below:

ByEnd-user:

  • Pharma And Biotech Companies
  • CROs

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global biopharmaceutical analytical testing services market growth

This study identifies increasing outsourcing of analytical testing services as the prime reasons driving the global biopharmaceutical analytical testing services market growth during the next few years.

Prominent vendors in global biopharmaceutical analytical testing services market

We provide a detailed analysis of around 25 vendors operating in the global biopharmaceutical analytical testing services market, including some of the vendors such as Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific, Intertek Group PLC, Merck KGaA, SGS SA, Solvias AG, STERIS Plc and West Pharmaceutical Services Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Pharma and biotech companies - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Boston Analytical
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Eurofins Scientific
  • Intertek Group PLC
  • Merck KGaA
  • SGS SA
  • Solvias AG
  • STERIS Plc
  • West Pharmaceutical Services Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Pharma and biotech companies - Market size and forecast 2019-2024 ($ million)
  • 25.Pharma and biotech companies - Year-over-year growth 2019-2024 (%)
  • 26.CROs - Market size and forecast 2019-2024 ($ million)
  • 27.CROs - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by End user
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.APAC - Market size and forecast 2019-2024 ($ million)
  • 37.APAC - Year-over-year growth 2019-2024 (%)
  • 38.South America - Market size and forecast 2019-2024 ($ million)
  • 39.South America - Year-over-year growth 2019-2024 (%)
  • 40.MEA - Market size and forecast 2019-2024 ($ million)
  • 41.MEA - Year-over-year growth 2019-2024 (%)
  • 42.Key leading countries
  • 43.Market opportunity by geography ($ million)
  • 44.Impact of drivers
  • 45.Impact of challenges
  • 46.Landscape disruption
  • 47.Industry risks
  • 48.Vendors covered
  • 49.Market positioning of vendors
  • 50.Boston Analytical - Overview (1/3)
  • 51.Boston Analytical - Overview (2/3)
  • 52.Boston Analytical - Overview (3/3)
  • 53.Boston Analytical - Product and service
  • 54.Boston Analytical - Key offerings
  • 55.Boston Analytical - Key customers
  • 56.Boston Analytical - Segment focus
  • 57.Catalent Inc. - Overview (1/3)
  • 58.Catalent Inc. - Overview (2/3)
  • 59.Catalent Inc. - Overview (3/3)
  • 60.Catalent Inc. - Business segments
  • 61.Catalent Inc. - Key offerings
  • 62.Catalent Inc. - Key customers
  • 63.Catalent Inc. - Segment focus
  • 64.Charles River Laboratories International Inc. - Overview (1/3)
  • 65.Charles River Laboratories International Inc. - Overview (2/3)
  • 66.Charles River Laboratories International Inc. - Overview (3/3)
  • 67.Charles River Laboratories International Inc. - Business segments
  • 68.Charles River Laboratories International Inc. - Key offerings
  • 69.Charles River Laboratories International Inc. - Key customers
  • 70.Charles River Laboratories International Inc. - Segment focus
  • 71.Eurofins Scientific - Overview (1/3)
  • 72.Eurofins Scientific - Overview (2/3)
  • 73.Eurofins Scientific - Overview (3/3)
  • 74.Eurofins Scientific - Business segments
  • 75.Eurofins Scientific - Key offerings
  • 76.Eurofins Scientific - Key customers
  • 77.Eurofins Scientific - Segment focus
  • 78.Intertek Group PLC - Overview (1/3)
  • 79.Intertek Group PLC - Overview (2/3)
  • 80.Intertek Group PLC - Overview (3/3)
  • 81.Intertek Group PLC - Product and service
  • 82.Intertek Group PLC - Key offerings
  • 83.Intertek Group PLC - Key customers
  • 84.Intertek Group PLC - Segment focus
  • 85.Merck KGaA - Overview (1/3)
  • 86.Merck KGaA - Overview (2/3)
  • 87.Merck KGaA - Overview (3/3)
  • 88.Merck KGaA - Business segments
  • 89.Merck KGaA - Key offerings
  • 90.Merck KGaA - Key customers
  • 91.Merck KGaA - Segment focus
  • 92.SGS SA - Overview (1/3)
  • 93.SGS SA - Overview (2/3)
  • 94.SGS SA - Overview (3/3)
  • 95.SGS SA - Business segments
  • 96.SGS SA - Key offerings
  • 97.SGS SA - Key customers
  • 98.SGS SA - Segment focus
  • 99.Solvias AG - Overview (1/3)
  • 100.Solvias AG - Overview (2/3)
  • 101.Solvias AG - Overview (3/3)
  • 102.Solvias AG - Business segments
  • 103.Solvias AG - Key offerings
  • 104.Solvias AG - Key customers
  • 105.Solvias AG - Segment focus
  • 106.STERIS Plc - Overview (1/3)
  • 107.STERIS Plc - Overview (2/3)
  • 108.STERIS Plc - Overview (3/3)
  • 109.STERIS Plc - Business segments
  • 110.STERIS Plc - Key offerings
  • 111.STERIS Plc - Key customers
  • 112.STERIS Plc - Segment focus
  • 113.West Pharmaceutical Services Inc. - Overview (1/3)
  • 114.West Pharmaceutical Services Inc. - Overview (2/3)
  • 115.West Pharmaceutical Services Inc. - Overview (3/3)
  • 116.West Pharmaceutical Services Inc. - Product and service
  • 117.West Pharmaceutical Services Inc. - Key offerings
  • 118.West Pharmaceutical Services Inc. - Key customers
  • 119.West Pharmaceutical Services Inc. - Segment focus
  • 120.Currency conversion rates for US$
  • 121.Research Methodology
  • 122.Validation techniques employed for market sizing
  • 123.Information sources
  • 124.List of abbreviations